Botanical species · safety record

Asclepias syriaca

The EFSA Compendium of Botanicals holds 9 constituent measurements for Asclepias syriaca. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Asclepias syriaca L.

9Constituent measurements

0Safety records

3Cited sources

3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Asclepias syriaca as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cardenolides	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Neolignans	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Gallic acid	Flower	Solvent extraction	0.05 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Nicotine	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
P-coumaric acid	Flower	Solvent extraction	≤ 5.56 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
P-coumaric acid	Flower	Solvent extraction	≥ 0.89 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
P-coumaric acid	Leaves	Solvent extraction	≤ 17.8 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
P-coumaric acid	Leaves	Solvent extraction	≥ 3.7 Microgram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Pyridine alkaloids	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Araya, Juan J., Kindscher, Kelly., Timmermann, Barbara N. Cytotoxic Cardiac Glycosides and Other Compounds from Asclepias Syriaca. Journal of natural products, 2012, vol. 75, no. 3, p. 400-407. DOI
Sikorska, M., Matlawska, I., Glowniak, K., Zgorka, G. Qualitative and quantitative analysis of phenolic acids in Asclepias syriaca L. . Acta poloniae pharmaceutica, 2000, vol. 57, no. 1, p. 69-72.
Kowalewski, Zdzislaw., Drost, Krystyna. Chromatographic research of alkaloids in the roots and leaves of Asclepias syriaca. Prace komisji farmaceutycznej, poznanskie towarzystwo przyjaciol nauk, 1966, vol. 5, p. 75-83.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature